Is Aurora Cannabis Inc. (TSX:ACB) Stock Still Oversold?
The Motley Fool
Published Jan 16, 2019 11:38
Updated Jan 16, 2019 12:07
Marijuana stocks are enjoying a new rally and investors who stayed on the sidelines through the downturn at the end of 2018 are wondering which pot stocks might be the best buys right now.
Let’s take a look at Aurora Cannabis portfolio today.
Acquisitions
Aurora Cannabis has been one of the more aggressive players in the Canadian marijuana market. The company made two major acquisitions in 2018 that consolidated the space and launched Aurora Cannabis into the big leagues among other large players such as Canopy Growth and Tilray.
The deals, which included the $2.5 billion takeover of MedReleaf in July and the $1.1 billion purchase of CanniMed in January, gave Aurora important production capacity and broader geographic coverage for both the Canadian medical marijuana market and the recently launched recreational market.
Aurora is continuing to grow in 2019. The company just announced a $175 million agreement to acquire Whistler Medical Marijuana. The deal adds production facilities in British Columbia, as well as a portfolio of premium products.
Overseas
Aurora also has its sights on a number of international opportunities, including Europe. The company is building a one million square foot greenhouse in Denmark with operations in Germany to serve the growing European medical marijuana market.
Diversified businesses
Aurora’s portfolio of companies includes investments in areas where cannabis products are expected to expand. The company has a 25% interest in Alcanna, the largest private sector alcohol retailer in Canada.
In the cosmetics segment, Aurora has a partnership with Envio Beauty to develop and market hemp seed oil and CBD-based lifestyle products.
The medical opportunities are also in the company’s sights. Aurora has a small ownership position in CTT Pharmaceuticals, which provides innovative drug delivery systems for pain treatment.
Finally, the sale of cannabis edibles is expected to be legalized in Canada at some point in 2019. Aurora has a majority interest in Hempco Food and Fiber, a hemp-based food company with more than a decade of experience in the sector.
Should you buy?
Aurora Cannabis currently trades at $9.60 per share, giving the company a market capitalization of about $9.6 billion. This provides management with the financial clout to continue to grow, and it wouldn’t be a surprise to see Aurora take a run at Aphria or HEXO in 2019.
Get The App
HEXO, in particular, might be an attractive target, as it would give Aurora a stronger presence in Quebec and also put it in a leadership position in the infused-drinks segment through the Truss partnership with Molson Coors Canada.
The stock is up significantly in the past week, but still sits well below the $15 peak it reached last year. I wouldn’t back up the truck, but Aurora might be an interesting pick today for investors who expect the marijuana sector to take off in the coming years.
Fool contributor Andrew Walker has no position in any stock mentioned.
This Article Was First Published on The Motley Fool
Written By: The Motley Fool
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.